Salvianolic Acid C - An Overview
Avoid coadministration of pazopanib with strong CYP3A4 inhibitors if at all possible; if ought to coadminister, decrease pazopanib dose to four hundred mg/dayMinor (1)dasatinib and pazopanib both of those raise QTc interval. Minimal/Significance Unknown.Prevent or Use Alternate Drug. Prevent coadministration of pazopanib with medications that raise